What is the recommended treatment for an adult with acute vestibular neuritis presenting with sudden prolonged vertigo, nausea, and gait instability after a viral upper‑respiratory infection, without hearing loss, tinnitus, or focal neurologic signs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Vestibular Neuritis

For an adult with acute vestibular neuritis presenting with sudden prolonged vertigo, nausea, and gait instability after a viral upper-respiratory infection, initiate oral corticosteroids within 3 days of symptom onset, provide short-term vestibular suppressants (≤3 days) for severe symptoms only, and begin early vestibular rehabilitation therapy as soon as the acute phase subsides.

Pharmacologic Management

Corticosteroid Therapy (Primary Treatment)

  • Oral corticosteroids accelerate recovery of vestibular function when initiated within 3 days of symptom onset and should be prescribed for otherwise healthy adults presenting early 1.
  • The evidence for long-term benefit remains uncertain, but steroids are reasonable for patients without contraindications who present acutely 1.
  • Withhold steroids from patients at higher risk of steroid-related complications (e.g., uncontrolled diabetes, severe hypertension, active infection) 1.

Symptomatic Medications (Acute Phase Only)

  • Vestibular suppressants (e.g., meclizine) and antiemetics are useful acutely but must be withdrawn after the first several days because prolonged use impedes central vestibular compensation 1, 2.
  • Meclizine is FDA-approved for vertigo associated with vestibular system diseases in adults 3.
  • Limit symptomatic medications to the acute phase only—typically the first 2–3 days—to relieve severe vertigo, nausea, and vomiting 1, 4.
  • Generalized supportive care includes hydration and antiemetics during the acute phase 2.

Antiviral and Vasodilator Therapy

  • Antiviral therapy and vasodilator therapy have been reported as specific drug options, though evidence for routine use is limited 2.
  • The pathogenesis likely involves reactivation of herpes simplex virus affecting the vestibular ganglion or nerve, but antiviral efficacy requires further validation 1, 4.

Vestibular Rehabilitation Therapy

  • Early resumption of normal activity should be encouraged immediately to promote central vestibular compensation 1.
  • Directed vestibular rehabilitation therapy accelerates recovery and should begin as soon as the acute phase subsides (typically after 2–3 days) 1, 2, 4.
  • Vestibular rehabilitation includes generalized vestibular exercises and customized vestibular exercises tailored to the patient's deficits 2.
  • Prolonged use of vestibular suppressants delays compensation; discontinue them early and transition to active rehabilitation 1, 4.

Diagnostic Confirmation and Red Flags

Confirming Vestibular Neuritis

  • Characteristic features include abrupt true-whirling vertigo lasting >24 hours, horizontal-torsional spontaneous nystagmus beating away from the lesion side, and absence of cochlear symptoms (no hearing loss, tinnitus, or aural fullness) 2, 4.
  • Abnormal head impulse test for the involved semicircular canals, ipsilesional caloric paresis, and unsteadiness with falling toward the lesion side confirm the diagnosis 4.
  • Vestibular neuritis preferentially involves the superior vestibular labyrinth; the posterior semicircular canal and saccule are usually spared 4.

When to Obtain Brain Imaging

  • Brain imaging (MRI preferred) is indicated when the patient has unprecedented severe headache, negative head impulse test, severe imbalance disproportionate to vertigo, or no recovery within 1–2 days 4.
  • Any focal neurological deficits (dysarthria, dysphagia, visual disturbances, limb weakness/numbness, Horner's syndrome) mandate immediate MRI to exclude posterior circulation stroke 5.
  • Direction-changing nystagmus without head position changes, downbeating nystagmus, or baseline nystagmus without provocative maneuvers are red flags requiring emergency imaging 5.
  • Patients with significant vascular risk factors (age >50, hypertension, diabetes, atrial fibrillation, prior stroke) should be evaluated for possible stroke even with typical vestibular neuritis features 1, 6.

Prognosis and Follow-Up

  • Most patients recover well from vestibular neuritis even without treatment, though steroids may accelerate recovery 1.
  • Vertigo typically peaks within 6–8 hours, gradually subsides over 7 days, and becomes tolerable by 10 days 7.
  • Despite proper treatment and rehabilitation, signs of dynamic vestibular imbalances may persist for months to a year in some patients 7.
  • Recurrence is possible, and patients should be counseled about the natural history and expected recovery timeline 2.

Common Pitfalls to Avoid

  • Do not prescribe vestibular suppressants beyond the first 2–3 days; prolonged use delays central compensation and prolongs recovery 1, 4.
  • Do not dismiss central causes in patients with atypical features (negative head impulse test, severe imbalance, no improvement after 1–2 days, or vascular risk factors) 4, 5.
  • Do not confuse vestibular neuritis with labyrinthitis; labyrinthitis includes profound hearing loss, whereas vestibular neuritis has no cochlear symptoms 8, 4.
  • Do not delay imaging if red flags are present; 75–80% of posterior circulation strokes presenting with acute vestibular syndrome lack focal deficits on initial examination 6.

References

Research

Treatment of vestibular neuritis.

Current treatment options in neurology, 2009

Research

Vestibular neuritis.

Seminars in neurology, 2013

Guideline

Differential Diagnosis of Vertigo with Fever and Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation of Dizziness Based on Cited Facts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clinical Presentation and Diagnosis of Labyrinthitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended management for vestibular neuritis?
What is the treatment for Vestibular (Vestibular) Neuritis?
What is the recommended treatment for vestibular neuritis, including available medication options in Canada?
What is the diagnosis and treatment for Vestibular (Vestibular) Neuritis?
What is the diagnosis and initial treatment for a patient with worsening dizziness (vertigo), mild earache (otalgia) bilaterally, fatigue, and lethargy after a recent viral exposure, with a positive head impulse test and negative Dix-Hallpike maneuver?
Can tenecteplase be given at the pulmonary embolism dose (0.5 mg/kg) for treatment of both pulmonary embolism and acute ischemic stroke?
In a patient with an acute ischemic stroke (within 4.5 h) who also has a confirmed pulmonary embolism (PE), what tenecteplase dose should be used and how should the two conditions be managed?
In a hemodynamically unstable patient with a massive pulmonary embolism who also has an acute ischemic stroke within the 4.5‑hour window, what systemic tenecteplase dose should be administered and how should the concurrent stroke be managed?
Should I start taking over‑the‑counter dietary supplements without first evaluating my nutritional needs, medical conditions, and current medications?
How should fungal elements detected on stool examination be managed in patients with diarrhea and risk factors such as recent broad‑spectrum antibiotics, immunosuppression, or gastrointestinal mucosal injury versus asymptomatic, otherwise healthy individuals?
What is the most likely diagnosis and recommended management for a child with continuous fever, cough, and diarrhea during an outbreak affecting many classmates?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.